Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Pharmacovigilance Reporting Associate/Senior Associate(Leader role) to join our diverse and dynamic team!-Location: Mexico City (office-based an average of 3 days per week)
Reference
JR129080
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Mexico, Mexico City
Location
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Senior Pharmacovigilance Systems Associate to join our diverse and dynamic team. As a Senior Pharmacovigilance Systems Associate at ICON, you will be pivotal in managing and
Reference
JR128071
Expiry date
01/01/0001
Read more
Shortlist Save this role
Salary
Location
Brazil, Sao Paulo
Location
Sao Paulo
Mexico City
Remote Working
Hybrid: Office/Remote
Job Categories
Drug Safety
Job Type
Permanent
Description
We are currently seeking a Senior Pharmacovigilance Intelligence Specialist to join our diverse and dynamic team!As a Senior Pharmacovigilance Intelligence Specialist at ICON, you will be responsible
Reference
JR127117
Expiry date
01/01/0001
Read more
Shortlist Save this role
.png)
Teaser label
IndustryContent type
BlogsPublish date
04/22/2025
Summary
When it comes to clinical trials, one of the most important documents you’ll hear about is the Informed Consent Form (ICF). Whether you're starting out in clinical research or exploring job opportunit
.png)
Teaser label
IndustryContent type
BlogsPublish date
04/17/2025
Summary
CRA vs CRC Embarking on a career in clinical research is an exciting journey for STEM graduates, offering opportunities to contribute directly to the development of new therapies and to safeguard
.png)
Teaser label
IndustryContent type
BlogsPublish date
04/07/2025
Summary
A Comprehensive Guide to Clinical Trial Agreements In the realm of clinical research, the foundation of a successful trial is built upon well-structured Clinical Trial Agreements (CTAs). These leg